Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
NPC Blog
NPC Blog
2010 Archives
2009 Archives
2008 Archives
2007 Archives
2006 Archives
Search Archives
Archives
  • December 2012 (3)
  • November 2012 (1)
  • October 2012 (1)
  • May 2012 (1)
  • December 2011 (1)
  • November 2011 (3)
  • October 2011 (4)
  • September 2011 (4)
  • August 2011 (6)
  • July 2011 (13)
  • June 2011 (8)
  • May 2011 (10)
  • April 2011 (14)
  • March 2011 (6)
  • February 2011 (2)
  • February 2010 (4)
  • January 2010 (1)
  • December 2009 (1)
  • November 2009 (1)
  • October 2009 (1)
  • September 2009 (2)
  • July 2009 (1)
  • April 2009 (1)
  • March 2009 (1)
  • February 2009 (1)
  • December 2008 (1)
  • October 2008 (1)
  • September 2008 (1)
  • August 2008 (2)
  • July 2008 (2)
  • June 2008 (4)
  • May 2008 (1)
  • April 2008 (1)
  • March 2008 (4)
  • February 2008 (1)
  • April 2007 (1)
  • December 2006 (1)
  • October 2006 (1)
  • September 2006 (1)
  • July 2006 (2)
  • June 2006 (3)
  •  

    Subscribe in a reader

    E-Alerts
    Signup to receive news and announcements from Nutra Pharma:
    First Name:
    Last Name:
    Email:
     
    Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

    NPC Blog

    New Social Networking Website for Rare Medical Disorders

    Congratulations to David Isserman for launching RareShare, a social enterprise website for patients and families affected by rare medical disorders. The Site hosts over 600 communities, each dedicated to specific rare condition.

    Although the Site is not owned by or affiliated with Nutra Pharma, David came up with the idea to launch the Site through his communications work here with Adrenomyeloneuropathy.

    We commend David on a job well done!

    -Rik


    SEC Disclaimer
    This article contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The Company's business is subject to various risks, which are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"). The above article, " New Social Networking Website for Rare Medical Disorders", should not be construed as an indication in any way whatsoever of: (a) the Company’s financial value; and/or (b) any predictive value of the Company’s future stock price. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

    del.icio.us:New Social Networking Website for Rare Medical Disorders digg:New Social Networking Website for Rare Medical Disorders spurl:New Social Networking Website for Rare Medical Disorders wists:New Social Networking Website for Rare Medical Disorders simpy:New Social Networking Website for Rare Medical Disorders newsvine:New Social Networking Website for Rare Medical Disorders blinklist:New Social Networking Website for Rare Medical Disorders furl:New Social Networking Website for Rare Medical Disorders reddit:New Social Networking Website for Rare Medical Disorders fark:New Social Networking Website for Rare Medical Disorders blogmarks:New Social Networking Website for Rare Medical Disorders Y!:New Social Networking Website for Rare Medical Disorders smarking:New Social Networking Website for Rare Medical Disorders magnolia:New Social Networking Website for Rare Medical Disorders segnalo:New Social Networking Website for Rare Medical Disorders gifttagging:New Social Networking Website for Rare Medical Disorders


    Comments

    No comments yet.

    RSS feed for comments on this post.

    TrackBack URL


    Leave a Comment

     
    Quick Nav
    Nyloxin // Chronic Pain Relief
    Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
     

     

     
    Recent News
     
    July 24, 2014
    Nutra Pharma Announces Infrastructure Improvements to Handle Increased Sales


    June 10, 2014
    Nutra Pharma Announces Contracts for Nyloxin Television Commercials


    January 07, 2014
    Nutra Pharma Announces the First Shipments and Product Delivery to MyNyloxin.com Independent Entrepreneurs


     
     
    Announcements
    Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
     
     
    Facebook   Twitter
     
    NPC
    Privacy Policy Code of Ethics